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Abstract  
Hepatic stellate cells are perisinusoidal cells characterized by vitamin A containing 
lipid droplets and 10 nm desmin filament in their cytoplasm. In an injured liver, stellate cells 
were activated through two major phase i.e, initiation and perpetuation which response to 
cytokines. It was postulated that hepatic stellate cell is a central component in the synthesis of 
large amounts of extra cellular matrix (ECM) that resulting in deposition of scar or fibrous 
tissue. In repeated injury, extra-cellular matrix altered composition accumulates, which is 
termed fibrosis. The ECM acts via specific domains that interact with cell receptors for 
cytokines such as Endothelin-1 and TGFβ  that are responsible for stimulating stellate cell 
activation and ECM production. The regulatory role of stellate cell activation and formation of 
excess ECM in liver injury offers new targets for therapeutic intervention in fibrosis. 
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Introduction 
Hepatic stellate cells known as 
Ito cells, lipocytes, fat-storing or 
perisinusoidal cells have emerged as a 
well-characterized cell type important to 
response in the process of liver injury.  
Since the stellate cells are not visible in 
standard tissue section of normal liver 
stained with hematoxylin and eosin, 
then immunocytochemical markers u-
sing desmin antibody was used to iden-
tify the stellate cells. Their relative 
abundance has been estimated at one 
third of the non-parenchymal population 
or about 15% of the total number of 
resident cells in normal liver. Major 
feature of stellate cells activation in liver 
injury of any type, include: increased 
proliferation, chemotaxis, enhanced pro-
duction of interstitial matrix, increased 
contractility, secretion of leukocyte che-
moattractans and cytokines, enhanced 
matrix degradation and loss of intra-
cellular retinoid. It was reported that 
granuloma were formed in the peri-
central area of Balb/c mice after a single 
injection of carbon tetrachloride. Direct 
contact between macrophages and 
stellate cells were frequently seen within 
the granulomas stimulated the diffe-
rentiation of stellate cells to myofibro-
balst-like cells caharacterized with small 
lipid droplet, well-developed granular 
endoplasic reticulum (rER), and thick 
bundles of intermediate filament in the 
cytoplasm. Collagen fibril were closely 
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applied to the stellate cells and connec-
tive tissue septa extended between 
neighboring granulomas after several 
injection of CCl4. It was suggested that 
stellate cells has a role in fibrogenic 
process by the production of excess extra 
cellular matrix (ECM).  1 
ECM refers to complexes of 
collagen and large collagen-associated 
glycoprotein. It has been reported that 
hepatic stellate cell is the major cellular 
source of extra cellular matrix either in 
normal or injured liver. The excess 
production of ECM is the most direct 
way that stellate cell activation generates 
hepatic fibrosis. The important role of 
stellate cells in ECM production has 
been established by combined evidence 
from in situ evaluation and from culture 
studies. The phenotype of stellate cells 
changes, both qualitatively and quanti-
tatively during liver injury. Overall there 
is a marked increase in cellular matrix 
production, especially the collagens 
types I, III that are synthesized and 
secreted by activated stellate. It has been 
a major focus of interest because of its 
importan-ce in the fibrotic scar.  
A number of specific antifibrotic 
therapies have been tried, but the result 
was poor or mediocre success. Howe-
ver, elucidation of the mechanisms res-
ponsible for fibrogenesis, with particular 
emphasis on stellate cell biology, has 
highlighted many putative novel thera-
pies. Stellate cell activation and regula-
tory role of ECM in liver injury offers 
new targets for therapeutic intervention 
in fibrosis. This article emphasizes me-
chanisms underlying fibrogenesis, and 
reviews current antifibrotic therapies as 
well as potential future approaches.  
 
 
Participation of  Stellate cells in  
hepatic fibrosis 
In normal liver, stellate cells are 
the primary site for storage of vitamin A, 
primarily as retinyl esters. Under flu-
orescence microscope, a strong vitamin 
A-fluorescence scattered within the 
hepatic lobules. In CCl4-induced liver 
fibrosis, vitamin A auto fluorescence 
was emitted from degenerating area 
surrounding central vein and extended 
septal area (Fig 1). 2 
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Fig. 1. Vitamin A autofluorescence was emited from stelatte cells 
surrounding central vein and extended septal area.  
 
 
 
Fig. 2.  Myofibroblast-like cells (MFC) with small lipid droplet (A), dilated 
cysterna of rough endoplasic reticulum (rER) and abundant collagen 
fibril resided surrounding central vein (CV). 
 
 
 
In liver of Balb/C mice, granulomas we-
re formed on day 5 after a single inject-
ion of CCl4. The granulomas contained 
several kind of inflammatory cells  i.e. 
monocytes, macrophages, and lympho-
cytes. On day 7 after injection, within the 
granulomas, stellate cells and macro-
phages were increased in number. 
Bundles of collagen fibers were scatter-
ed close to stellate cells. Ultrastruc-
turally examination with Transmission 
Electron Microscope demonstrated the 
myofibro-blast-like cells (differentiated 
from stellate cels) characterized with less 
lipid droplet, dilated cysterna of rough 
endo-plasmic reticulum (rER) and 
abundant collagen fibril resided to the 
cells (fig 2).1  
Desmin immunoreactivity in 
normal liver tissue of ICR mice was 
identified in smooth muscle in the walls 
of blood vessel and in perisinusoidal 
stellate cells surrounding sinusoids. 
Strong desmin immunoreaction was 
observed in the hepatic pericentral area 
and septal area after several injection of 
CCl4.  (Fig. 3).2 
The fact that various diseases 
result in cirrhosis suggests a common 
pathogenesis. A growing body of lite-
rature indicates that the hepatic stellate 
cell is a central component in the fibro-
genic process.  Stellate cells undergo a 
transformation during injury that has 
been termed activation. Activation is 
complex and multifaceted, but one of its 
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most prominent features is the synthesis 
of large amounts of extracellular matrix, 
resulting in deposition of scar or fibrous 
tissue. 
 
 
 
 
Fig. 3. Desmin-positive stellate cells with long cytoplasmic processus in the  
pericentral  and septal area 
 
 
 
A central feature of the fibro-
genic response is the transformation of 
stellate cells from quiescent to an activat-
ed state. Although simple in concept, the 
activation process is remarkably com-
plex and consists of many important 
cellular changes. Characteristic features 
of this transition include loss of vitamin 
A, acquisition of stress bundles, and de-
velopment of prominent rough endo-
plasmic reticulum. 3 
 
 
Stellate Cell Activation 
In liver injury, stellate cells 
undergo a process known as activation. 
Stellate cells activation represent a 
cascade of cellular events common to all 
form of liver injury , including  viral 
hepatitis, alcohol, toxic injury and 
genetic liver disease. Activation consists 
of two major phases, initiation and 
perpetuation. Initiation refers to early 
changes in gene expression and 
phenotype which response to cytokines. 
Perpetuation is maintaining the activat-
ed phenotype and generating fibrosis. 
Initiation is largely due to paracrine 
stimulation, where as perpetuation 
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involves autocrine as well as paracrine 
loops. 
 
Initiation phase 
The intimate association between 
stellate cells and neighboring sinusoidal 
cells, including sinusoidal endothelium, 
Kupffer cells, hepatocytes, and platelets 
may facilitate paracrine stimulation by 
soluble mediators. The paracrine and/ 
or autocrine secretion of various 
cytokines modulate the inflammatory 
response in liver injury. Recent studies 
suggest that activations of stellate cells 
is provoked by generation of free 
radicals in culture and is blocked by 
antioxidants. These activations may 
involve the transcription factor NF kβ.4  
 
Perpetuation phase 
Perpetuation of stellate cell activation 
involves at least seven distinct activa-
tiondependent functional changes i.e: 
proliferation, migration into regions of 
injury, contractility, fibrogenesis, cyto-
kine release, matrix protease rele-
ase/activity, and retinoid loss. Either 
directly or indirectly, the net effect of 
these changes is to increase accumu-
lation of extra cellular matrix. 4  
 
 
Regulatory factors of  
Stellate cell fibrogenesis  
Multiple factors play a key 
pathogenic role in stellate cell fibro-
genesis. Prominent among these factors 
are cytokines, small peptides, and the 
extracellular matrix itself. Transforming 
growth factor-B-1 (TGF-B1) appears to 
be the most profibrogenic cytokine pre-
sent in the liver. TGF-B1 is produced in a 
paracrine manner by Kupffer cells, 
sinusoidal endothelial cells, bile duct 
epithelial cells, hepatocytes, or by 
stellate cells themselves. TGF-B1 pro-
duction by stellate cells is important, and 
thus points to this cytokine as a classic 
autocrine factor. When over expressed in 
the liver, it leads to fibrosis, and when 
inhibited during experimental liver 
injury, fibrosis is decreased. 
Cytokines and growth factors 
that drive stellate cell included platelet-
derived growth factor (PDGF), monocyte 
chemotactic factor, insulin-like growth 
factors-1 and -2, interleukin-6, hepato-
cyte growth factor, and vasoactive pepti-
des :  endothelin-1 and angiotensin II.3 
Increased activity of cytokines may be 
critical for both autocrine and paracrine 
perpetuation of stellate cell activation. 
 
Stellate Cell in Extracellular  
Matrix production 
ECM refers collectively to com-
plexes of collagen and large collagen-
associated glycoprotein5. ECM com-
plexes are quiet diverse, the ECM 
around the biliary epithelium is different 
from that associated with hepatocytes 
and within the the space of Disse asso-
ciated with stellate cells and sinusoidal 
endothelial cells. The ECM is highly 
dynamic and capable of undergoing 
rapid change in response to injury. The 
hepatic stellate cell is the major cellular 
source of extra-cellular matrix (ECM) in 
normal and injured liver. The important 
role of stellate cells in ECM production 
has been established by combined 
evidence from in situ evaluation by 
immunohisto chemistry and nuclei acid 
hybridization, from culture studies, and 
from analysis of freshly isolated stellate 
cells from normal or injured liver.6,7   The 
matrix phenotype of stellate cells 
changes, both qualitatively and quanti-
tatively during liver injury. Overall there 
is a marked increase in cellular matrix 
production, and a shift from basement 
membrane-like matrix containing non-
fibril forming collagens  e.g, type IV, VI  
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to so-called interstitial matrix rich  in 
fibril-forming collagens types I, III.  Syn-
thesis and secretion of collagen type I by 
activated stellate has been a major focus 
of interest because of its importance in 
the fibrotic scar, and because regulatory 
mechanisms for collagen I gene ex-
pression have been well characterized in 
other systems.7    Direct effects on stellate 
cell matrix production and contractility 
have been attributed to autocrine TGFβ  
and endothelin-1, respectively.8,9 The in-
flammatory component may be ampli-
fied by increased MCP-1 production by 
activated stellate cells.10 
 
 
The ECM and Wound repair         
The response to injury is one of 
wound healing and, subsequently, fibro-
sis. This response is generalized, occur-
ring in diverse organ systems. Injury and 
wounding in the liver ultimately lead to 
cirrhosis in many patients.  The change 
in ECM that follow injury to the liver, as 
well as other epithelia, funda-mentally 
represent wound repair. Their role as 
ECM producers is to bind the wound 
and possibly to restrict spread of the 
injury. Pathological fibrosis, or “scar”, 
represents on-going or multiple cycles of 
repair and contraction in response to 
chronic or repetitive injury.  
The finding that liver ”myo-
fibroblasts” represent for the most part 
activated stellate cells, focusing attention 
on the regulation of activation. It is clear, 
moreover, that this represents a common 
response to injury of diverse etiology. 
Chronic biliary obstruction and alcoholic 
hepatitis cause pathology initially in 
different areas of  the lobule, but in both 
cases the activation of stellate cells is 
prominent. The ECM has a central role 
in contraction, providing the fiber net to 
which stellate cells attach and through 
which their contractile force is trans-
mitted. Endothelin 1 induces contract-
ion, proliferation, and collagen synthesis 
of hepatic stellate cells in vitro, which 
may be mediated via the endothelin A 
receptor. It is speculated if specific 
blockade of the endothelin A receptor 
inhibits hepatic fibrosis in vivo. 11 
 
 
 
 
New targets for therapeutic 
intervention in fibrosis  
The current understanding of 
stellate cell-ECM interaction in liver in-
jury, while far from complete, has yield-
ed several new targets for therapeutic 
manipulation of fibrogenesis. Although 
stellate  cell activation occurs after both 
acute and chronic liver injury, only 
chronic and not acute injury result in 
progressive fibrosis.  Stellate cell activ-
ation is a key therapeutic target in 
treating hepatic fibrosis and associated 
portal hypertention. Antifibrotic and 
hemodynamic effects of the early and 
chronic administration of octreotide in 
two models of liver fibrosis in rats were 
reported. The early and chronic adminis-
tration of octreotide prevents the deve-
lopment of portocollateral blood flow 
without reducing portal pressure in the 
CCl4 model liver fibrosis.12  A new cate-
gory of antifibrotic agents are those that 
act directly on stellate cells to modulate 
their activation. Given their global 
effects on the activation response, they 
are assumed to act at the level of the 
nucleus, therefore interferon is one such 
compound13. In conjuction with these 
studies, the drug was noted to elicit a 
greater response in female animals than 
in males. Moreover, this difference was 
demonstrable with stellate cells isolated 
from females and males and placed in 
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primary culture. The suggestion of a 
sexual dimorphism of wound repair 
may be relevant to the fact that in 
chronic liver injury, the progression of 
fibrosis to cirrhosis and its compli-
cations such as hepatocellular carcinoma 
is more rapid in men than in women. 
The data suggest further that it may be 
necessary to devise different anti-fibrotic 
regimens for men and women, and 
different intensity of the treatment. 
Finally, contractile antagonists 
are attractive therapeutically because of 
the dynamic nature of contraction. In 
theory they are capable of reversing an 
injury-related increase in intrahepatic 
pressure and thereby reducing the risk 
of complication such as variceal bleed-
ing. Selective endothelin-A receptor 
blockade can dramatically reduce colla-
gen accumulation in rat secondary bi-
liary fibrosis, a model refractory to most 
potential antifibrotic agents. Endothelin-
A receptor antagonists are promising 
antifibrotic agents in chronic liver 
disease.14  Antagonists of mediators that 
regulate both activating and contractile 
stimuli are already undergoing testing in 
experimental models of liver injury, and 
will likely emerge in clinical trials in the 
coming decade.  Study of  anti fi-brotic 
effects in vitro and in vivo models of 
liver fibrosis in rats demonstrated that 
inhibition of PDGF and TGF-beta1 
actions on hepatic stellate cell provide a 
possible mechanism of its antifibrotic 
activities. 15 
 
 
Conclusion 
Progress continues on defining of two 
major phases of stellate cells activation 
i.e., initiation and perpetuation.  The in-
jury response of the liver is increasingly 
well understood with regard to the role 
of individual cell types such as sinuso-
idal endothelial cells and stellate cells.  
Furthermore cytokines such as TGF-B1 
and PDGF play a key pathogenic role in 
stellate cell fibrogenesis. Transforming 
growth factor-B-1 (TGF-B1) appears to 
be the most profibrogenic cytokine 
present in the liver. The targets for anti-
fibrotic therapy are receptors for those 
cytokines such as TGFβ and endothelin 1 
that are responsible for stimulating 
stellate cell activation and ECM product-
ion. Thereby Endothelin-A receptor 
antagonists are promising antifibrotic 
agents in chronic liver disease. Their 
regulation at a molecular level is a topic 
of current investigation. 
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